Homocystinuria Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyze | Orphan Technologies, Traverse Therapeutics, Synlogic

DelveInsight's "Homocystinuria Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Homocystinuria, historical and forecasted epidemiology as well as the Homocystinuria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Homocystinuria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Homocystinuria Market Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Homocystinuria Market Report:
• The Homocystinuria market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Nearly 45,000 cases of Homocystinuria were reported to be widespread overall in the 7MM in 2022, according to DelveInsight data
• In the US, 14,000 cases of Homocystinuria were detected overall in 2022. The number of these cases is expected to rise between 2019 and 2032.
• Germany had the most total and frequent Homocystinuria cases among the EU4 and the UK in 2022, while Spain had the fewest cases.
• In May 2023, Travere Therapeutics announced positive results from cohort 6 in the placebo-controlled Phase I/IICOMPOSE Study of pegtibatinase, a novel investigational enzyme replacement therapy being evaluated for the treatment of classical homocystinuria (HCU). Till date,pegtibatinase has been generally well-tolerated.
• Males and females are equally affected by homocystinuria owing to CBS deficiency, which is classified as an uncommon disorder by the National Organization for uncommon Disorders (NORD). According to population surveys, 1 in 344,000 people worldwide are thought to have homocystinuria. According to estimates, the prevalence in Germany is 1 in 17,500 cases
• The age group of 55-74 years old had the highest age-specific prevalence cases
• Key Homocystinuria Companies: Orphan Technologies, Travere Therapeutics, Synlogic, and others
• Key Homocystinuria Therapies: Pegtibatinase(TVT-058), SYNB1353, and others
• The Homocystinuria market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Homocystinuria pipeline products will significantly revolutionize the Homocystinuria market dynamics.

Homocystinuria Overview
The hereditary rare amino acid metabolism illness known as homocystinuria (HCU) is characterized by the body's improper processing of the amino acid methionine, which results in an abnormal build-up of homocysteine and its metabolites in the urine and blood. These metabolites are typically not detectable in blood or urine in significant amounts.

Get a Free sample for the Homocystinuria Market Report
https://www.delveinsight.com/report-store/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Homocystinuria Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Homocystinuria Epidemiology Segmentation:
The Homocystinuria market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Homocystinuria
• Prevalent Cases of Homocystinuria by severity
• Gender-specific Prevalence of Homocystinuria
• Diagnosed Cases of Episodic and Chronic Homocystinuria

Download the report to understand which factors are driving Homocystinuria epidemiology trends @ Homocystinuria Epidemiology Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Homocystinuria Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Homocystinuria market or expected to get launched during the study period. The analysis covers Homocystinuria market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Homocystinuria Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Homocystinuria Therapies and Key Companies
• Pegtibatinase(TVT-058): Orphan Technologies/TravereTherapeutics
• SYNB1353: Synlogic

Discover more about therapies set to grab major Homocystinuria market share @ Homocystinuria Treatment Market
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Homocystinuria Market Strengths
• Improvement in diagnostic procedures like, New Born Screening Systems, has been a major factor in making the diagnosis of HCU much less complicated. Along with detecting elevated methionine (Met) level, analysis of total homocysteine (tHcy) as a second tier marker and calculating the Met/tHcy ratio is also recommended bylatest guidelines and this might leads to increase in diagnosis of HCU

Homocystinuria Market Opportunities
• The strong clinical development of novel therapeutics will have a positive effect on the market. Most of the groups and companies involved in research related to homocystinuria are also working towards improving the current diagnosis rate as well and this will provide the larger windows of opportunity for emerging therapies.

Scope of the Homocystinuria Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Homocystinuria Companies: Orphan Technologies, TravereTherapeutics, Synlogic, and others
• Key Homocystinuria Therapies: Pegtibatinase(TVT-058), SYNB1353, and others
• Homocystinuria Therapeutic Assessment: Homocystinuria current marketed and Homocystinuria emerging therapies
• Homocystinuria Market Dynamics: Homocystinuria market drivers and Homocystinuria market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Homocystinuria Unmet Needs, KOL's views, Analyst's views, Homocystinuria Market Access and Reimbursement

To know more about Homocystinuria companies working in the treatment market, visit @ Homocystinuria Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Homocystinuria Market Report Introduction
2. Executive Summary for Homocystinuria
3. SWOT analysis of Homocystinuria
4. Homocystinuria Patient Share (%) Overview at a Glance
5. Homocystinuria Market Overview at a Glance
6. Homocystinuria Disease Background and Overview
7. Homocystinuria Epidemiology and Patient Population
8. Country-Specific Patient Population of Homocystinuria
9. Homocystinuria Current Treatment and Medical Practices
10. Homocystinuria Unmet Needs
11. Homocystinuria Emerging Therapies
12. Homocystinuria Market Outlook
13. Country-Wise Homocystinuria Market Analysis (2019-2032)
14. Homocystinuria Market Access and Reimbursement of Therapies
15. Homocystinuria Market Drivers
16. Homocystinuria Market Barriers
17. Homocystinuria Appendix
18. Homocystinuria Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Homocystinuria Pipeline https://www.delveinsight.com/report-store/homocystinuria-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Homocystinuria Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Homocystinuria market. A detailed picture of the Homocystinuria pipeline landscape is provided, which includes the disease overview and Homocystinuria treatment guidelines.
Homocystinuria Epidemiology https://www.delveinsight.com/report-store/homocystinuria-epidemiology-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Homocystinuria Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Homocystinuria epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight

Substance Use Disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market
DelveInsight's "Substance Use Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance Use Disorder, historical and forecasted epidemiology as well as the Substance Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Tongue Cancer Market
https://www.delveinsight.com/report-store/tongue-cancer-market
DelveInsight's "Tongue Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tongue Cancer, historical and forecasted epidemiology as well as the Tongue Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Tumor Ablation Market
https://www.delveinsight.com/report-store/tumor-ablation-market
DelveInsight's 'Tumor Ablation Market Insight, Competitive Landscape, and Market Forecast - 2030' report delivers an in-depth understanding of Tumor Ablation and the historical and forecasted Tumor Ablation market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Type 2 Diabetes Market
https://www.delveinsight.com/report-store/type-2-diabetes-market
DelveInsight's "Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of Type 2 Diabetes, historical and forecasted epidemiology as well as the Type 2 Diabetes market trends in the United States, EU4 (Germany, Spain, Italy, France), and the United Kingdom, and Japan.

Varicose Vein Market
https://www.delveinsight.com/report-store/varicose-veins-market
DelveInsight's "Varicose Veins Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Varicose Veins, historical and forecasted epidemiology as well as the Varicose Veins market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.